newsfilter
← Latest News
GlobeNewswire·

Conavi Medical Reports Fiscal Third Quarter 2026 Results and Operational Highlights

Net loss for Fiscal Q3 2026 was $6.3 million (Fiscal Q3 2025 - $3.6 million) reflecting continued investment in research and development activities of $4.4 million (Fiscal Q3 2025 - $3.2 million) Ended Fiscal Q3 2026